OGT Launches NGS Panel to Detect Residual Disease in Acute Myeloid Leukemia
The RNA-based panel detects leukemia-associated gene fusions at levels as low as 1% tumor cells, offering another approach to monitoring residual disease.
Latest Articles
Editor's Top Picks
Broader Screening Criteria Double Positive Results for Primary Aldosteronism, Study Finds
A study of 60,449 lab results found that using broader screening thresholds doubled detection rates of primary aldosteronism compared to Endocrine Society guidelines, according to research in Hypertension.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
Diatech Pharmacogenetics Acquires SensoQuest, Launches Labcycler Thermal Cycler for Molecular Testing
Diatech Pharmacogenetics has acquired SensoQuest and launched the Labcycler PCR thermal cycler, expanding into laboratory instrumentation with a platform rated for up to 600,000 cycles and manufactured in Italy.
Equipment & Supply Spotlight
Revvity Launches AI-First Platform to Coordinate Lab Workflows from Discovery to Manufacturing
The Signals LabGistics tool translates standard operating procedures into scientific workflows and supports GxP compliance across laboratory environments.
News, Know-How & Standards
Disease Detection & Understanding
Labcorp and Waters Partner to Offer Extended-Genotype BD Onclarity HPV Assay Nationwide
Labcorp plans to offer the HPV test through clinician-collected and self-collected screening options beginning in late 2026, providing extended genotyping to help guide cervical cancer risk assessment.
